AMERICAN SHARED HOSPITAL SERVICES Depreciation
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Depreciation of $5.17 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2024-04-01
- AMERICAN SHARED HOSPITAL SERVICES depreciation for the quarter ending 2023-12-31 was $1.29M, a 5.30% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES depreciation for the quarter ending 2023-09-30 was $1.26M, a 7.02% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES depreciation for the quarter ending 2023-06-30 was $1.24M, a 6.79% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES depreciation for the quarter ending 2023-03-31 was $1.37M.
- AMERICAN SHARED HOSPITAL SERVICES depreciation for fiscal 2023 was $5.17M, a 7.99% increase from fiscal 2022.
- AMERICAN SHARED HOSPITAL SERVICES depreciation for fiscal 2022 was $4.78M, a 3.80% decline from fiscal 2021.
- AMERICAN SHARED HOSPITAL SERVICES depreciation for fiscal 2021 was $4.97M.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2023-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $2.56M derived: sum of 2 quarters · filed 2024-04-01 | $3.80M derived: sum of 3 quarters · filed 2024-04-01 | $5.17M 10-K · filed 2024-04-01 |
| 2023-09-30 | $1.26M 10-Q · filed 2023-11-14 | $2.51M derived: sum of 2 quarters · filed 2023-11-14 | $3.87M 10-Q · filed 2023-11-14 | $5.10M derived: sum of 4 quarters · filed 2024-04-01 |
| 2023-06-30 | $1.24M 10-Q · filed 2023-08-14 | $2.61M 10-Q · filed 2023-08-14 | $3.83M derived: sum of 3 quarters · filed 2024-04-01 | $5.02M derived: sum of 4 quarters · filed 2024-04-01 |
| 2023-03-31 | $1.37M derived: 10-K 12 month − 3 quarters · filed 2024-04-01 | $2.59M derived: sum of 2 quarters · filed 2024-04-01 | $3.77M derived: sum of 3 quarters · filed 2024-04-01 | $4.94M derived: sum of 4 quarters · filed 2024-04-01 |
| 2022-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $2.41M derived: sum of 2 quarters · filed 2024-04-01 | $3.57M derived: sum of 3 quarters · filed 2024-04-01 | $4.78M 10-K · filed 2024-04-01 |
| 2022-09-30 | $1.18M 10-Q · filed 2023-11-14 | $2.35M derived: sum of 2 quarters · filed 2023-11-14 | $3.56M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $1.16M 10-Q · filed 2023-08-14 | $2.38M 10-Q · filed 2023-08-14 | ||
| 2021-12-31 | $4.97M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |